Gene Sequencing – to the Bedside | Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Feeds:: Posts; Comments

« The Promise of Personalized Medicine

DNA Sequencing Technology »

Gene Sequencing – to the Bedside

March 3, 2013 by larryhbern

Gene Sequencing – to the Bedside

Reporter: Larry H Bernstein, MD, FCAP

Gene sequencing leaves the laboratory

Maturing technology speeds medical diagnoses.

Erika Check Hayden 19 February 2013

The steep fall in the cost of sequencing a genome has, for the moment, slowed. Yet researchers attending this year’s Advances in Genome Biology and Technology (AGBT) meeting in Marco Island, Florida, on 20–23 February are not complaining. At a cost as low as US$5,000–10,000 per human genome, sequencing has become cheap and reliable enough that researchers are not waiting for the next sequencing machine to perfect new applications in medicine.

http://www.nature.com/polopoly_fs/7.9051.1361287131!/image/Slide2.jpg_gen/derivatives/landscape_630/Slide2.jpg

Single-cell genomics is allowing fertility clinics to screen embryos for abnormalities more cheaply.

http://www.nature.com/news/gene-sequencing-leaves-the-laboratory-1.12454?WT.ec_id=NATURE-20130221

Human genome to genes

Human genome to genes (Photo credit: Wikipedia)

Genome sequencing of the Healthy (pharmaceuticalintelligence.com)
2013 Genomics: The Era Beyond the Sequencing Human Genome: Francis Collins, Craig Venter, Eric Lander, et al. (pharmaceuticalintelligence.com)
Gene sequencing leaves the laboratory (nature.com)
Real Time Genomics Announces Platform Launch, Expanding Commercial Operations (prweb.com)
Solid-State Sequencer Debuts at Genome Conference (technologyreview.com)
Research and Markets: DNA Sequencing – Technologies, Markets and Companies – 2013 (prweb.com)

Posted in International Global Work in Pharmaceutical, Molecular Genetics & Pharmaceutical, Personalized and Precision Medicine & Genomic Research, Pharmaceutical Industry Competitive Intelligence, Pharmaceutical R&D Investment, Population Health Management, Genetics & Pharmaceutical | Tagged AGBT, Biology, DNA, DNA sequencer, Florida, genetics, genome, Genome Biology, human genome, Marco Island Florida | 3 Comments

3 Responses

on March 4, 2013 at 4:58 AM | Reply How Genes Function | Pharmaceutical Intelligence

[…] Gene Sequencing – to the bedside (pharmaceuticalintelligence.com) […]

Loading...
on March 4, 2013 at 5:09 AM | Reply suraiyahaider

Reblogged this on medchemhot.

Loading...
on March 4, 2013 at 5:41 AM | Reply lindaedwards689

Reblogged this on medchemhotsun.

Loading...

Leave a Reply Cancel reply

Follow Blog via Email

Enter your email address to follow this blog and receive notifications of new posts by email.

Join 2,655 other subscribers

Email Address
Recent Posts
- NCCN Shares Latest Expert Recommendations for Prostate Cancer in Spanish and Portuguese September 14, 2021
- Standard Operating Procedures for Updating the Map of LPBI India August 24, 2021
- New avenues for research in membrane biology reveals the mobility of protein at work August 23, 2021
- Can the Public Benefit Company Structure Save US Healthcare? August 20, 2021
- Patients with type 2 diabetes may soon receive artificial pancreas and a smartphone app assistance August 13, 2021
- CNS immune interface August 9, 2021
- 3D printing: Improvising the Next-generation Batteries August 8, 2021
- Novartis uses a ‘dimmer switch’ medication to fine-tune gene therapy candidates August 7, 2021
- LPBI Group announces 5th Academic INTERNSHIP as a Verifiable Certificate in Financial Modeling & Econometrics as One Semester or as One Year Program open to Undergraduate and MBA students August 7, 2021
- Science Policy Forum: Should we trust healthcare explanations from AI predictive systems? July 31, 2021
Archives
Archives
Categories
Categories
Meta

%d bloggers like this: